Abstract
This research seeks to evaluate the efficacy and efficiency of clinical-trial strategic partnerships by examining their connections to the country's regulatory agencies. The country's formal institutions, i.e. its defined norms, are what ultimately govern the behaviour of social actors. A strategic alliance is a voluntary, long-term cooperation arrangement between two or more independent businesses with complementary strengths and objectives in order to gain a market advantage. Organizational effectiveness and efficiency are reflected in the performance of clinical-trial strategic alliances, which are structured according to the contractual relationship and the relational capabilities of the parties to overcome challenges in the partnership's activities and ensure intercompany cooperation. This research built on a previous critical literature assessment by proposing new hypotheses on the connections between national regulatory bodies and international partnerships for testing experimental pharmaceuticals in humans.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.